Edge Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
OIM
BC
CC
JMPWA
ACH
BIT
NM
BFA
Edge Wealth Management's AXDX Position: Q3 2016 in Review
Edge Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q3 2016, closing a stake of 100 shares — an estimated $14K sold.
Edge Wealth Management first reported a position in AXDX in Q3 2015 and held it in 4 quarters. The position peaked at $21K in Q4 2015. 103 funds tracked by Wall St. Rank hold AXDX as of Q3 2016.
- Edge Wealth Management reported no remaining Accelerate Diagnostics position as of Q3 2016 after selling out during the quarter.
- Edge Wealth Management sold 100 Accelerate Diagnostics shares in Q3 2016, an estimated $14K.
- Edge Wealth Management first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 4 quarters.
- Edge Wealth Management's Accelerate Diagnostics position peaked at $21K in Q4 2015.
- 103 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2016.
Based on Edge Wealth Management's 13F filing for Q3 2016, filed 13 Oct 2016.